Antibody

1,032개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved1,032 programs
AntibodyLimited DatastaleAstraZenecaPhase 1

durvalumab (Imfinzi, IPH5401 and Durvalumab)

Advanced Solid Tumors · Advanced Solid Tumors

#AdvancedSolidTumors#Antibody#Phase1#monoclonal-antibody#AstraZeneca
Trials 1Status Discontinued
AntibodyLimited DatastaleUniversity of Colorado, DenverPhase 1

IPI-926 and Cetuximab (IPI-926 and Cetuximab)

Recurrent Head and Neck Cancer · Recurrent Head and Neck Cancer

#RecurrentHeadandNeckCancer#Antibody#Phase1#monoclonal-antibody#University
Trials 1Status Active
AntibodyLimited DatastaleMerckPreclinical

pembrolizumab, tislelizumab, sintilimab, camrelizumab, and toripalimab (Immune Checkpoint Inhibitors, Immune Checkpoint Inhibitors ( pembrolizumab, tislelizumab, sintilimab, camrelizumab, and toripalimab))

Esophageal Squamous Cell Carcinoma (ESCC) · Esophageal Squamous Cell Carcinoma (ESCC

#EsophagealSquamousCellCarcinomaE#Antibody#Preclinical#monoclonal-antibody#Merck
Trials 1Status Recruiting
AntibodyLimited DatastaleBristol-Myers SquibbPreclinical

nivolumab (Opdivo, Immuno-oncology-based therapy, excluding nivolumab-based regimens, Immuno-oncology-based therapy (excluding nivolumab-based regimens) with chemotherapy)

Non-small Cell Lung Cancer (NSCLC) · Non-small Cell Lung Cancer (NSCLC)

#Non-smallCellLungCancerNSCLC#Antibody#Preclinical#monoclonal-antibody#Bristol-Myers
Trials 1Status Recruiting
AntibodyLimited DatastaleEli LillyPhase 3

Imprime PGG + cetuximab (Imprime PGG + cetuximab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase3#monoclonal-antibody#Eli
Trials 1Status Discontinued
AntibodyLimited DatastaleVanda PharmaceuticalsPhase 2

Imsidolimab (Imsidolimab)

Ichthyosis · Ichthyosis

#Ichthyosis#Antibody#Phase2#monoclonal-antibody#Vanda
Trials 1Status Discontinued
AntibodyLimited DatastaleJanssenPhase 3

Induction dose of (Induction dose of, Induction dose of (a) infliximab followed by combination of (b) pegylated interferon alfa-2b and (c) ribavirin)

Hepatitis C, Chronic · Hepatitis C, Chronic

#HepatitisCChronic#Antibody#Phase3#monoclonal-antibody#HepatitisC+2
Trials 1Status Active
AntibodyLimited DatastaleFeng JinzhouPreclinical

Inebilizumab (Inebilizumab)

Neuromyelitis Optica Spectrum Disorders · Neuromyelitis Optica Spectrum Disorders

#NeuromyelitisOpticaSpectrumDisor#Antibody#Preclinical#monoclonal-antibody#Feng
Trials 1Status Active
AntibodyLimited DatastaleJanssenApproved

Innovator infliximab (Innovator infliximab)

Rheumatoid Arthritis; Spondyloarthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#monoclonal-antibody#Spondyloarthritis+1
Trials 1Status Active
AntibodyLimited DatastalePfizerPhase 3

Inotuzumab (Inotuzumab)

Acute Lymphoblastic Leukemia · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#Antibody#Phase3#monoclonal-antibody#Pfizer
Trials 1Status Discontinued
AntibodyLimited DatastaleNorthwell HealthPhase 1

trastuzumab (Herceptin, Intra-arterial Cerebral Infusion of Trastuzumab)

Neoplasm Metastasis · Neoplasm Metastasis

#NeoplasmMetastasis#Antibody#Phase1#monoclonal-antibody#Northwell
Trials 1Status Discontinued
AntibodyLimited DatastaleEli LillyPhase 2

Intra-arterial Cetuximab (Intra-arterial Cetuximab)

Glioblastoma; Anaplastic Astrocytoma · Glioblastoma

#Glioblastoma#Antibody#Phase2#monoclonal-antibody#AnaplasticAstrocytoma+1
Trials 1Status Recruiting
AntibodyLimited DatastaleJanssenPhase 3

Intraarticular injection of infliximab (Intraarticular injection of infliximab)

Arthritis · Arthritis

#Arthritis#Antibody#Phase3#monoclonal-antibody#Janssen
Trials 1Status Discontinued
AntibodyLimited DatastaleKhon Kaen UniversityPhase 3

Intralesional injection of bevacizumab (Intralesional injection of bevacizumab)

Pterygium; Inflammation · Pterygium

#Pterygium#Antibody#Phase3#monoclonal-antibody#Inflammation+1
Trials 1Status Active
AntibodyLimited DatastaleHospices Civils de LyonPhase 2

nivolumab (Opdivo, IP, Intraperitoneal, Intraperitoneal (IP) nivolumab infusion)

Ovarian Cancer · Ovarian Cancer

#OvarianCancer#Antibody#Phase2#monoclonal-antibody#Hospices
Trials 1Status Active
AntibodyLimited DatastaleEastern Regional Medical CenterPhase 1

Intraperitoneal Bevacizumab (Intraperitoneal Bevacizumab)

Malignant Ascites · Malignant Ascites

#MalignantAscites#Antibody#Phase1#monoclonal-antibody#Eastern
Trials 1Status Discontinued
AntibodyLimited DatastaleRochePhase 2

Intrathecal Rituximab (Intrathecal Rituximab)

Leukemia; Lymphoid Malignancies · Leukemia

#Leukemia#Antibody#Phase2#monoclonal-antibody#LymphoidMalignancies+1
Trials 1Status Discontinued
AntibodyLimited DatastaleShanghai Cancer Hospital, ChinaPhase 2

nivolumab (Opdivo, Intraventricular Nivolumab)

Leptomeningeal Metastasis · Leptomeningeal Metastasis

#LeptomeningealMetastasis#Antibody#Phase2#monoclonal-antibody#Shanghai
Trials 1Status Recruiting
AntibodyLimited DatastaleSir Run Run Shaw HospitalPhase 2

Ipalolimab and Tovorilimab (Ipalolimab and Tovorilimab)

dMMR/MSI-H-type Rectal Adenocarcinoma · dMMR/MSI-H-type Rectal Adenocarcinoma

#dMMRMSI-H-typeRectalAdenocarcino#Antibody#Phase2#monoclonal-antibody#dMMR+2
Trials 1Status Recruiting
AntibodyLimited DatastaleTianjin Medical University Canc…Phase 2

Iparomlimab and tuvonralimab (Iparomlimab and tuvonralimab)

HCC - Hepatocellular Carcinoma; Iparomlimab and Tuvonralimab Injection · mCRC

#mCRC#Antibody#Phase2#monoclonal-antibody#HCC-HepatocellularCarcinoma+2
Trials 1Status Recruiting

30 / 52 pages

← PreviousNext →